![PDF) Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest | Gianluca Tomasello - Academia.edu PDF) Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest | Gianluca Tomasello - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/76814430/mini_magick20211219-27607-ynt4yq.png?1639901477)
PDF) Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest | Gianluca Tomasello - Academia.edu
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorect
![Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a9d53b31-f719-4a73-9368-5af7d2d8be2b/gr1.jpg)
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del
Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in pati
![Carcinoma colorettale: linee di ricerca, innovazioni e sfide future. Congresso a Pisa - insalutenews.it Carcinoma colorettale: linee di ricerca, innovazioni e sfide future. Congresso a Pisa - insalutenews.it](https://www.insalutenews.it/in-salute/wp-content/uploads/2016/06/prof-alfredo-falcone-direttore-polo-oncologico-aoup-e1574425631425.png)
Carcinoma colorettale: linee di ricerca, innovazioni e sfide future. Congresso a Pisa - insalutenews.it
Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience
Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorec
![Le meraviglie… nel paese di Alice': lo spettacolo con protagonisti medici, infermieri e pazienti - gonews.it Le meraviglie… nel paese di Alice': lo spettacolo con protagonisti medici, infermieri e pazienti - gonews.it](https://www.gonews.it/wp-content/uploads/2019/03/29marzo-def.jpg)
Le meraviglie… nel paese di Alice': lo spettacolo con protagonisti medici, infermieri e pazienti - gonews.it
![Frontiers | Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial | Oncology Frontiers | Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial | Oncology](https://www.frontiersin.org/files/Articles/925366/fonc-12-925366-HTML/image_m/fonc-12-925366-g001.jpg)
Frontiers | Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial | Oncology
![Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer | Request PDF Clinical significance of enterocyte-specific gene polymorphisms as candidate markers of oxaliplatin-based treatment for metastatic colorectal cancer | Request PDF](https://i1.rgstatic.net/publication/349031046_Clinical_significance_of_enterocyte-specific_gene_polymorphisms_as_candidate_markers_of_oxaliplatin-based_treatment_for_metastatic_colorectal_cancer/links/601d5b5ba6fdcc37a80610e5/largepreview.png)